What the FDA labels say about taking them together
Inavolisib and loperamide
Inavolisib's FDA label of April 21, 2026 names loperamide in its warnings and precautions section; the loperamide label PlainMeds reads does not name inavolisib. The inavolisib label: “Advise patients to start anti-diarrheal treatment, increase oral fluids, and notify their healthcare provider if severe diarrhea occurs.”
Check it at the source: the inavolisib FDA label on DailyMed (effective April 21, 2026, Genentech, Inc.); the loperamide FDA label on DailyMed (effective June 3, 2026, Aurobindo Pharma Limited).
What does the inavolisib label say about loperamide?
Inavolisib label, warnings and precautionsAdvise patients to start anti-diarrheal treatment, increase oral fluids, and notify their healthcare provider if severe diarrhea occurs.
Source: FDA drug label (Itovebi), Genentech, Inc., effective April 21, 2026 (SPL set 5de59f5b-e5db-410f-b692-658686ef4107), via openFDA; the full label on DailyMed
What does the loperamide label say about inavolisib?
Loperamide's label (effective June 3, 2026) does not name inavolisib in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Loperamide Hydrochloride), Aurobindo Pharma Limited, effective June 3, 2026 (SPL set 8e4004be-bf79-4631-9e38-c4e7b6726313), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Inavolisib | Loperamide | |
|---|---|---|
| Labeled for | n/a | Diarrhea |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | n/a | $0.0549 per capsule 2 mg capsule |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once